HCM
STJ

Highbridge Capital Management’s St Jude Medical STJ Stock Holding History

Highbridge Capital Management’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-4,300
Closed -$314K – 2001
2015
Q2 		$314K Sell
4,300
-12,100
-74% -$874K ﹤0.01% 1131
2015
Q1 		$1.07M Buy
+16,400
New +$1.09M 0.01% 729

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Highbridge Capital Management's STJ Position: Q1 2017 in Review

Highbridge Capital Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 34,366 shares — an estimated $2.75M sold.

Highbridge Capital Management first reported a position in STJ in Q1 2014 and held it in 7 quarters. The position peaked at $21.8M in Q2 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Highbridge Capital Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Highbridge Capital Management sold 34,366 St Jude Medical shares in Q1 2017, an estimated $2.75M.
  • Highbridge Capital Management first reported a position in St Jude Medical in Q1 2014 and held it in 7 quarters.
  • Highbridge Capital Management's St Jude Medical position peaked at $21.8M in Q2 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Highbridge Capital Management's 13F filing for Q1 2017, filed 15 May 2017.